You are here

OTC

GSK joins other drugmakers recalling Zantac products

GSK joins other drugmakers recalling Zantac products

Fierce Pharma

product recalls

Flag link:

GlaxoSmithKline halts generic Zantac supply as global threat gains steam

GlaxoSmithKline halts generic Zantac supply as global threat gains steam

Fierce Pharma

product recalls

Flag link:

GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks

GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks

Fierce Pharma

advisory panels

Flag link:

Zantac and some OTC meds found to contain suspected carcinogen first discovered in blood pressure drugs

Zantac and some OTC meds found to contain suspected carcinogen first discovered in blood pressure drugs

Fierce Pharma

Flag link:

GSK split edges closer as OTC joint venture deal with Pfizer closes

GSK split edges closer as OTC joint venture deal with Pfizer closes

Pharmaforum

Flag link:

Roche cuts loose Tamiflu OTC rights, handing Sanofi the keys as the pharma giant doubles down on Xofluza

Roche cuts loose Tamiflu OTC rights, handing Sanofi the keys as the pharma giant doubles down on Xofluza

Endpoints

Flag link:

Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit

Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit

BioSpace

Flag link:

Daiichi Sankyo in talks over OTC unit sale – reports

Daiichi Sankyo in talks over OTC unit sale – reports

Pharmaforum

Flag link:

Taisho Nears $1.6 Billion Deal for Bristol-Myers Unit

Taisho Nears $1.6 Billion Deal for Bristol-Myers Unit

Bloomberg

Bristol-Myers Squibb

Flag link:

Crown Laboratories buys select OTC consumer healthcare brands from GSK

Crown Laboratories buys select OTC consumer healthcare brands from GSK

Pharmaceutical Business Review

Crown Laboratories

Flag link:

Takeda considering sale of OTC business in Europe ($11bn)

Takeda considering sale of OTC business in Europe ($11bn)

Bloomberg

Flag link:

Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)

Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)

GoinPharma

Bristol-Myers Squibb

Flag link:

Children’s Advil Recalled by Pfizer Due to Dosing Issues

Children’s Advil Recalled by Pfizer Due to Dosing Issues

Xtalks

Flag link:

Anthem, Walmart Partner On Senior Access To OTC Medicines

Anthem, Walmart Partner On Senior Access To OTC Medicines

Forbes

Flag link:

FDA Taking Steps to Empower Consumers' Use of Nonprescription Drugs

FDA Taking Steps to Empower Consumers' Use of Nonprescription Drugs

CP Wire

Flag link:

Pressure mounts on drug makers to move birth control over the counter

Pressure mounts on drug makers to move birth control over the counter

Stat

Flag link:

With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?

With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?

Forbes

erectile dysfunction

Flag link:

Teva and Procter & Gamble Sever OTC Partnership

Teva and Procter & Gamble Sever OTC Partnership

CP Wire

Teva Pharmaceutical

Procter & Gamble

Flag link:

With U.S. brand sales deflating, Pfizer gears up for over-the-counter Viagra in U.K.

With U.S. brand sales deflating, Pfizer gears up for over-the-counter Viagra in U.K.

Fierce Pharma

erectile dysfunction

Flag link:

Are Amazon’s Private Label OTC Medications a Stepping Stone to Prescription Drug Sales?

Are Amazon’s Private Label OTC Medications a Stepping Stone to Prescription Drug Sales?

Xtalks

Flag link:

Pages